Rusfertide: Presentation of data from P3 VERIFY trial (NCT05210790) for polycythemia vera at ASH (Dec 6-9, 2025) (Protagonist Therapeutics) - Jun 2, 2025 - ASCO 2025
P3 data • Hematological Malignancies • Myeloproliferative Neoplasm • Oncology • Polycythemia Vera
|